126 related articles for article (PubMed ID: 7379441)
21. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
[TBL] [Abstract][Full Text] [Related]
22. Kinetic and clinical observations in cyanotic children on propranolol therapy.
Riopel DA; Walle T
Clin Pharmacol Ther; 1980 Dec; 28(6):743-50. PubMed ID: 7438690
[TBL] [Abstract][Full Text] [Related]
23. The effect of ageing on the hepatic clearance of propranolol.
Castleden CM; George CF
Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
[TBL] [Abstract][Full Text] [Related]
24. No stereoselective first-pass hepatic extraction of propranolol.
Jackman GP; McLean AJ; Jennings GL; Bobik A
Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
[TBL] [Abstract][Full Text] [Related]
25. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
Pritchard F; Schneck D; Hayes A
Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
[TBL] [Abstract][Full Text] [Related]
26. Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response.
Sowinski KM; Burlew BS
Pharmacotherapy; 1997; 17(6):1305-10. PubMed ID: 9399616
[TBL] [Abstract][Full Text] [Related]
27. Quantitative account of propranolol metabolism in urine of normal man.
Walle T; Walle UK; Olanoff LS
Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
[TBL] [Abstract][Full Text] [Related]
28. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
Walle T; Wilson MJ; Walle UK; Bai SA
Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent disposition of oral propranolol in normal subjects.
Mackichan JJ; Pyszczynski DR; Jusko WJ
Biopharm Drug Dispos; 1980; 1(4):159-66. PubMed ID: 7448344
[TBL] [Abstract][Full Text] [Related]
30. Interaction between oral propranolol and hydralazine.
McLean AJ; Skews H; Bobik A; Dudley FJ
Clin Pharmacol Ther; 1980 Jun; 27(6):726-32. PubMed ID: 7379440
[TBL] [Abstract][Full Text] [Related]
31. Altered S(--)-propranolol disposition in bilateral ureter-ligated rats.
Laganière S; Shen DD
Nephron; 1987; 46(3):305-11. PubMed ID: 3627324
[TBL] [Abstract][Full Text] [Related]
32. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
33. Presystemic and systemic glucuronidation of propranolol.
Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of propranolol in the human maternal-placental-foetal unit.
Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacokinetics of propranolol.
Routledge PA; Shand DG
Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
Wong L; Nation RL; Chiou WL; Mehta PK
Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
[TBL] [Abstract][Full Text] [Related]
37. Partial metabolic clearances as determinants of the oral bioavailability of propranolol.
Walle T; Walle UK; Olanoff LS; Conradi EC
Br J Clin Pharmacol; 1986 Sep; 22(3):317-23. PubMed ID: 3768243
[TBL] [Abstract][Full Text] [Related]
38. Propranolol disposition in renal failure.
Wood AJ; Vestal RE; Spannuth CL; Stone WJ; Wilkinson GR; Shand DG
Br J Clin Pharmacol; 1980 Dec; 10(6):561-6. PubMed ID: 7470370
[TBL] [Abstract][Full Text] [Related]
39. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
von Bahr C; Hermansson J; Lind M
J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
Christ DD; Walle UK; Oatis JE; Walle T
Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
